The Desk
PEPTIDE INTELLIGENCE
Deep dives, stack guides, vendor spotlights, and regulatory updates. Written by the Stacked editorial desk, no sponsorship deals, no rewritten press releases, no medical advice.
5 articles · for research purposes only
Featured
5 Peptide Reconstitution Mistakes That Quietly Destroy Your Stack
The most expensive mistake in peptide protocols isn't the compound you chose. It's how you stored it. Five handling errors cover ~90% of what we see go wrong, and a vial that looks identical to day one can be 30% less potent by week three if you treated it wrong.
Latest
4 entries
BPC-157 and the Cancer Question: What the SRS Episode Missed
Louisa Nicola raised a real concern about BPC-157 and angiogenesis on SRS #300. The clip economy turned a 'we don't know' into 'BPC-157 causes cancer.' Here's the whole picture, including the 2025 peer-reviewed review most clips left out.
Retatrutide in 2026: Where the Science Actually Stands
Retatrutide's 2026 status, Phase 3 TRIUMPH program, ~24% Phase 2 weight loss, MASH hepatic-fat data, regulatory timeline, and the current research-chemical market across tracked vendors.
Best Places to Buy Peptides Online in 2026: The Honest Review
An honest review of the best places to buy peptides online in 2026, scored against our published methodology, with pricing, pros, cons, and red flags for every tracked vendor.
Tirzepatide vs Semaglutide vs Retatrutide: The Complete 2026 Comparison
Tirzepatide vs semaglutide vs retatrutide, a clinical, trial-grounded 2026 comparison of the three GLP-1 class peptides on efficacy, safety, availability, and cost.